Annual report pursuant to Section 13 and 15(d)

Stock Options (Details Narrative)

v3.20.1
Stock Options (Details Narrative) - USD ($)
12 Months Ended
Dec. 23, 2019
Dec. 31, 2019
Dec. 31, 2018
Number of stock options granted   2,531,971 1,400,418
Exercise price of common stock granted   $ 2.07 $ 6.75
Number of common stock exercised   32,508
Number of common stock exercised, value     $ 34,000
Employees and Consultants [Member]      
Number of stock options granted 1,340,333 2,531,971 1,400,418
Exercise price of common stock granted $ 1.36 $ 2.07 $ 6.75
Fair value before amendment amount $ 32,000    
Stock based compensation expenses 12,000    
Recognized of operating expense $ 20,000    
Expiration period   5 years 5 years
Stock option vesting period   4 years 4 years
Fair value of stock options grants   $ 4,564,000 $ 9,712,000
Expense recognized relating to stock options   1,961,000 $ 1,870,000
Unrecognized stock based compensation expense   $ 4,228,000  
Stock option, description   Expected to be recognized as part of operating expense through December 2023